Challenger (ASX:CGF) has finalised a capital partnership with Auckland-based mortgage lender Finbase, committing NZ$150 million to deepen its footprint in New Zealand's expanding private credit market ...

BSP Financial Group (ASX:BFL) has launched an investigation alongside leading external cyber experts following the detection of unauthorised third-party access to its back-office test environment. The ...

Dell Technologies is poised to add $81 billion in market value as surging demand for Nvidia-powered AI servers drives a massive boost to its ...

Coronado Global Resources (ASX:CRN) has finalised an agreement to divest 100% of its interest in the Logan Mining Complex, located in West Virginia, USA. The Australian-listed coal producer will sell ...

Dexus (ASX:DXS) has stood down key executives, axed adviser JPMorgan, and placed its $7.3B infrastructure unit under review. Jeremy Siegel, Professor Emeritus of Finance at the Wharton School, ...

ImmunityBio (NASDAQ:IBRX) announced positive results Tuesday from its ANKTIVA® clinical program, signaling a potential paradigm shift in the treatment of advanced non-small cell lung cancer (NSCLC) ...

The Australian Competition and Consumer Commission has issued a directive to the nation’s financial institutions, demanding an urgent overhaul of due diligence processes following a massive mortgage ...

Australian life insurer TAL announced an expansion of its long-term partnership with Microsoft. The bolstered five-year agreement is designed to accelerate the integration of cloud infrastructure and ...

The Duratec Ertech joint venture has been awarded a $281 million contract by the Department of Defence. The project focuses on critical upgrades at HMAS Stirling, specifically targeting the Diamantina ...

Elixir Energy (ASX:EXR) has formalised an early works agreement with APA Group (ASX:APA) to fast-track the commercialisation of its Taroom Trough assets. The partnership focuses on conducting ...

Mesoblast shares were in focus Monday after the company announced positive formal feedback from the U.S. Food and Drug Administration (FDA) regarding its allogeneic cell therapy, rexlemestrocel-L. The ...

Meta Platforms (NASDAQ:META) is projected to surpass Alphabet's Google (NASDAQ:GOOG) in global digital advertising revenue by the end of 2026, ending Google’s long-standing reign as the dominant force ...